nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7—Tacrolimus—atopic dermatitis	0.0765	0.107	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0765	0.107	CbGbCtD
Nefazodone—CYP3A5—Tacrolimus—atopic dermatitis	0.0574	0.08	CbGbCtD
Nefazodone—CYP3A4—Pimecrolimus—atopic dermatitis	0.0376	0.0524	CbGbCtD
Nefazodone—ABCB1—Tacrolimus—atopic dermatitis	0.0373	0.0521	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0311	0.0434	CbGbCtD
Nefazodone—CYP3A7—Hydrocortisone—atopic dermatitis	0.0311	0.0434	CbGbCtD
Nefazodone—ABCB1—Loratadine—atopic dermatitis	0.0273	0.0381	CbGbCtD
Nefazodone—CYP2D6—Loratadine—atopic dermatitis	0.0258	0.0359	CbGbCtD
Nefazodone—CYP2D6—Diphenhydramine—atopic dermatitis	0.0258	0.0359	CbGbCtD
Nefazodone—ABCB1—Methylprednisolone—atopic dermatitis	0.025	0.0348	CbGbCtD
Nefazodone—CYP3A5—Hydrocortisone—atopic dermatitis	0.0234	0.0326	CbGbCtD
Nefazodone—CYP3A4—Tacrolimus—atopic dermatitis	0.0224	0.0312	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.0194	0.027	CbGbCtD
Nefazodone—CYP3A7—Dexamethasone—atopic dermatitis	0.0194	0.027	CbGbCtD
Nefazodone—CYP3A4—Loratadine—atopic dermatitis	0.0164	0.0228	CbGbCtD
Nefazodone—ABCB1—Betamethasone—atopic dermatitis	0.0163	0.0227	CbGbCtD
Nefazodone—ABCB1—Prednisolone—atopic dermatitis	0.016	0.0224	CbGbCtD
Nefazodone—ABCB1—Hydrocortisone—atopic dermatitis	0.0152	0.0212	CbGbCtD
Nefazodone—ABCB1—Prednisone—atopic dermatitis	0.0151	0.0211	CbGbCtD
Nefazodone—CYP3A4—Methylprednisolone—atopic dermatitis	0.015	0.0209	CbGbCtD
Nefazodone—CYP3A5—Dexamethasone—atopic dermatitis	0.0145	0.0203	CbGbCtD
Nefazodone—CYP3A4—Triamcinolone—atopic dermatitis	0.0114	0.0158	CbGbCtD
Nefazodone—CYP3A4—Betamethasone—atopic dermatitis	0.00974	0.0136	CbGbCtD
Nefazodone—CYP3A4—Prednisolone—atopic dermatitis	0.00961	0.0134	CbGbCtD
Nefazodone—ABCB1—Dexamethasone—atopic dermatitis	0.00945	0.0132	CbGbCtD
Nefazodone—CYP3A4—Hydrocortisone—atopic dermatitis	0.00911	0.0127	CbGbCtD
Nefazodone—CYP3A4—Prednisone—atopic dermatitis	0.00907	0.0127	CbGbCtD
Nefazodone—CYP2D6—Dexamethasone—atopic dermatitis	0.00891	0.0124	CbGbCtD
Nefazodone—CYP3A4—Dexamethasone—atopic dermatitis	0.00566	0.0079	CbGbCtD
Nefazodone—Angioedema—Methylprednisolone—atopic dermatitis	0.000139	0.000519	CcSEcCtD
Nefazodone—Haemorrhage—Prednisone—atopic dermatitis	0.000138	0.000517	CcSEcCtD
Nefazodone—Myalgia—Hydrocortisone—atopic dermatitis	0.000138	0.000515	CcSEcCtD
Nefazodone—Hallucination—Prednisone—atopic dermatitis	0.000138	0.000514	CcSEcCtD
Nefazodone—Malaise—Triamcinolone—atopic dermatitis	0.000138	0.000514	CcSEcCtD
Nefazodone—Anxiety—Hydrocortisone—atopic dermatitis	0.000137	0.000513	CcSEcCtD
Nefazodone—Malaise—Methylprednisolone—atopic dermatitis	0.000137	0.000512	CcSEcCtD
Nefazodone—Vertigo—Triamcinolone—atopic dermatitis	0.000137	0.000512	CcSEcCtD
Nefazodone—Syncope—Triamcinolone—atopic dermatitis	0.000137	0.000511	CcSEcCtD
Nefazodone—Vertigo—Methylprednisolone—atopic dermatitis	0.000137	0.000511	CcSEcCtD
Nefazodone—Syncope—Methylprednisolone—atopic dermatitis	0.000136	0.00051	CcSEcCtD
Nefazodone—Discomfort—Hydrocortisone—atopic dermatitis	0.000136	0.000509	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000135	0.000505	CcSEcCtD
Nefazodone—Oedema—Prednisolone—atopic dermatitis	0.000135	0.000505	CcSEcCtD
Nefazodone—Vomiting—Tacrolimus—atopic dermatitis	0.000135	0.000503	CcSEcCtD
Nefazodone—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000134	0.000501	CcSEcCtD
Nefazodone—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000134	0.000499	CcSEcCtD
Nefazodone—Rash—Tacrolimus—atopic dermatitis	0.000134	0.000499	CcSEcCtD
Nefazodone—Dermatitis—Tacrolimus—atopic dermatitis	0.000133	0.000498	CcSEcCtD
Nefazodone—Shock—Prednisolone—atopic dermatitis	0.000133	0.000497	CcSEcCtD
Nefazodone—Cough—Triamcinolone—atopic dermatitis	0.000133	0.000497	CcSEcCtD
Nefazodone—Headache—Tacrolimus—atopic dermatitis	0.000133	0.000496	CcSEcCtD
Nefazodone—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000132	0.000494	CcSEcCtD
Nefazodone—Oedema—Hydrocortisone—atopic dermatitis	0.000132	0.000494	CcSEcCtD
Nefazodone—Convulsion—Triamcinolone—atopic dermatitis	0.000132	0.000493	CcSEcCtD
Nefazodone—Tachycardia—Prednisolone—atopic dermatitis	0.000132	0.000493	CcSEcCtD
Nefazodone—Convulsion—Methylprednisolone—atopic dermatitis	0.000132	0.000492	CcSEcCtD
Nefazodone—Hypertension—Triamcinolone—atopic dermatitis	0.000132	0.000492	CcSEcCtD
Nefazodone—Hypertension—Methylprednisolone—atopic dermatitis	0.000131	0.000491	CcSEcCtD
Nefazodone—Infection—Hydrocortisone—atopic dermatitis	0.000131	0.00049	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000131	0.000489	CcSEcCtD
Nefazodone—Shock—Hydrocortisone—atopic dermatitis	0.00013	0.000486	CcSEcCtD
Nefazodone—Myalgia—Triamcinolone—atopic dermatitis	0.00013	0.000485	CcSEcCtD
Nefazodone—Arthralgia—Methylprednisolone—atopic dermatitis	0.00013	0.000484	CcSEcCtD
Nefazodone—Myalgia—Methylprednisolone—atopic dermatitis	0.00013	0.000484	CcSEcCtD
Nefazodone—Anxiety—Methylprednisolone—atopic dermatitis	0.000129	0.000482	CcSEcCtD
Nefazodone—Tachycardia—Hydrocortisone—atopic dermatitis	0.000129	0.000482	CcSEcCtD
Nefazodone—Flushing—Prednisone—atopic dermatitis	0.000128	0.00048	CcSEcCtD
Nefazodone—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000128	0.000479	CcSEcCtD
Nefazodone—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000128	0.000479	CcSEcCtD
Nefazodone—Discomfort—Triamcinolone—atopic dermatitis	0.000128	0.000479	CcSEcCtD
Nefazodone—Discomfort—Methylprednisolone—atopic dermatitis	0.000128	0.000478	CcSEcCtD
Nefazodone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000128	0.000477	CcSEcCtD
Nefazodone—Dry mouth—Triamcinolone—atopic dermatitis	0.000127	0.000474	CcSEcCtD
Nefazodone—Angioedema—Betamethasone—atopic dermatitis	0.000126	0.000472	CcSEcCtD
Nefazodone—Angioedema—Dexamethasone—atopic dermatitis	0.000126	0.000472	CcSEcCtD
Nefazodone—Anorexia—Hydrocortisone—atopic dermatitis	0.000126	0.000471	CcSEcCtD
Nefazodone—Nausea—Tacrolimus—atopic dermatitis	0.000126	0.00047	CcSEcCtD
Nefazodone—Confusional state—Methylprednisolone—atopic dermatitis	0.000125	0.000468	CcSEcCtD
Nefazodone—Malaise—Betamethasone—atopic dermatitis	0.000125	0.000466	CcSEcCtD
Nefazodone—Malaise—Dexamethasone—atopic dermatitis	0.000125	0.000466	CcSEcCtD
Nefazodone—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000124	0.000465	CcSEcCtD
Nefazodone—Oedema—Triamcinolone—atopic dermatitis	0.000124	0.000465	CcSEcCtD
Nefazodone—Vertigo—Dexamethasone—atopic dermatitis	0.000124	0.000464	CcSEcCtD
Nefazodone—Vertigo—Betamethasone—atopic dermatitis	0.000124	0.000464	CcSEcCtD
Nefazodone—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000124	0.000464	CcSEcCtD
Nefazodone—Syncope—Dexamethasone—atopic dermatitis	0.000124	0.000463	CcSEcCtD
Nefazodone—Syncope—Betamethasone—atopic dermatitis	0.000124	0.000463	CcSEcCtD
Nefazodone—Infection—Triamcinolone—atopic dermatitis	0.000124	0.000462	CcSEcCtD
Nefazodone—Hypotension—Hydrocortisone—atopic dermatitis	0.000124	0.000461	CcSEcCtD
Nefazodone—Infection—Methylprednisolone—atopic dermatitis	0.000123	0.000461	CcSEcCtD
Nefazodone—Shock—Triamcinolone—atopic dermatitis	0.000122	0.000457	CcSEcCtD
Nefazodone—Insomnia—Prednisolone—atopic dermatitis	0.000122	0.000457	CcSEcCtD
Nefazodone—Alopecia—Prednisone—atopic dermatitis	0.000122	0.000457	CcSEcCtD
Nefazodone—Shock—Methylprednisolone—atopic dermatitis	0.000122	0.000456	CcSEcCtD
Nefazodone—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000122	0.000454	CcSEcCtD
Nefazodone—Loss of consciousness—Betamethasone—atopic dermatitis	0.000122	0.000454	CcSEcCtD
Nefazodone—Paraesthesia—Prednisolone—atopic dermatitis	0.000122	0.000454	CcSEcCtD
Nefazodone—Tachycardia—Triamcinolone—atopic dermatitis	0.000121	0.000454	CcSEcCtD
Nefazodone—Tachycardia—Methylprednisolone—atopic dermatitis	0.000121	0.000453	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.00012	0.00045	CcSEcCtD
Nefazodone—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.00012	0.000449	CcSEcCtD
Nefazodone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.00012	0.000448	CcSEcCtD
Nefazodone—Convulsion—Dexamethasone—atopic dermatitis	0.00012	0.000448	CcSEcCtD
Nefazodone—Convulsion—Betamethasone—atopic dermatitis	0.00012	0.000448	CcSEcCtD
Nefazodone—Insomnia—Hydrocortisone—atopic dermatitis	0.00012	0.000446	CcSEcCtD
Nefazodone—Hypertension—Dexamethasone—atopic dermatitis	0.000119	0.000446	CcSEcCtD
Nefazodone—Hypertension—Betamethasone—atopic dermatitis	0.000119	0.000446	CcSEcCtD
Nefazodone—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000119	0.000443	CcSEcCtD
Nefazodone—Myalgia—Dexamethasone—atopic dermatitis	0.000118	0.00044	CcSEcCtD
Nefazodone—Myalgia—Betamethasone—atopic dermatitis	0.000118	0.00044	CcSEcCtD
Nefazodone—Anxiety—Betamethasone—atopic dermatitis	0.000117	0.000438	CcSEcCtD
Nefazodone—Anxiety—Dexamethasone—atopic dermatitis	0.000117	0.000438	CcSEcCtD
Nefazodone—Discomfort—Betamethasone—atopic dermatitis	0.000116	0.000435	CcSEcCtD
Nefazodone—Discomfort—Dexamethasone—atopic dermatitis	0.000116	0.000435	CcSEcCtD
Nefazodone—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000116	0.000435	CcSEcCtD
Nefazodone—Hypotension—Methylprednisolone—atopic dermatitis	0.000116	0.000433	CcSEcCtD
Nefazodone—Pain—Prednisolone—atopic dermatitis	0.000116	0.000432	CcSEcCtD
Nefazodone—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000115	0.000429	CcSEcCtD
Nefazodone—Vision blurred—Prednisone—atopic dermatitis	0.000114	0.000424	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000113	0.000423	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000113	0.000423	CcSEcCtD
Nefazodone—Pain—Hydrocortisone—atopic dermatitis	0.000113	0.000422	CcSEcCtD
Nefazodone—Oedema—Betamethasone—atopic dermatitis	0.000113	0.000422	CcSEcCtD
Nefazodone—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000113	0.000422	CcSEcCtD
Nefazodone—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000113	0.000422	CcSEcCtD
Nefazodone—Oedema—Dexamethasone—atopic dermatitis	0.000113	0.000422	CcSEcCtD
Nefazodone—Insomnia—Triamcinolone—atopic dermatitis	0.000113	0.00042	CcSEcCtD
Nefazodone—Insomnia—Methylprednisolone—atopic dermatitis	0.000112	0.000419	CcSEcCtD
Nefazodone—Infection—Betamethasone—atopic dermatitis	0.000112	0.000419	CcSEcCtD
Nefazodone—Infection—Dexamethasone—atopic dermatitis	0.000112	0.000419	CcSEcCtD
Nefazodone—Ill-defined disorder—Prednisone—atopic dermatitis	0.000112	0.000418	CcSEcCtD
Nefazodone—Paraesthesia—Triamcinolone—atopic dermatitis	0.000112	0.000417	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisolone—atopic dermatitis	0.000112	0.000417	CcSEcCtD
Nefazodone—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000112	0.000416	CcSEcCtD
Nefazodone—Anaemia—Prednisone—atopic dermatitis	0.000111	0.000416	CcSEcCtD
Nefazodone—Shock—Betamethasone—atopic dermatitis	0.000111	0.000415	CcSEcCtD
Nefazodone—Shock—Dexamethasone—atopic dermatitis	0.000111	0.000415	CcSEcCtD
Nefazodone—Dyspnoea—Triamcinolone—atopic dermatitis	0.000111	0.000414	CcSEcCtD
Nefazodone—Agitation—Prednisone—atopic dermatitis	0.000111	0.000414	CcSEcCtD
Nefazodone—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000111	0.000413	CcSEcCtD
Nefazodone—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000111	0.000413	CcSEcCtD
Nefazodone—Tachycardia—Dexamethasone—atopic dermatitis	0.00011	0.000412	CcSEcCtD
Nefazodone—Tachycardia—Betamethasone—atopic dermatitis	0.00011	0.000412	CcSEcCtD
Nefazodone—Angioedema—Prednisone—atopic dermatitis	0.00011	0.000411	CcSEcCtD
Nefazodone—Dyspepsia—Triamcinolone—atopic dermatitis	0.00011	0.000409	CcSEcCtD
Nefazodone—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000109	0.000408	CcSEcCtD
Nefazodone—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000109	0.000408	CcSEcCtD
Nefazodone—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000109	0.000408	CcSEcCtD
Nefazodone—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000109	0.000407	CcSEcCtD
Nefazodone—Malaise—Prednisone—atopic dermatitis	0.000109	0.000406	CcSEcCtD
Nefazodone—Vertigo—Prednisone—atopic dermatitis	0.000108	0.000404	CcSEcCtD
Nefazodone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000108	0.000404	CcSEcCtD
Nefazodone—Syncope—Prednisone—atopic dermatitis	0.000108	0.000404	CcSEcCtD
Nefazodone—Anorexia—Dexamethasone—atopic dermatitis	0.000108	0.000402	CcSEcCtD
Nefazodone—Anorexia—Betamethasone—atopic dermatitis	0.000108	0.000402	CcSEcCtD
Nefazodone—Urticaria—Prednisolone—atopic dermatitis	0.000108	0.000402	CcSEcCtD
Nefazodone—Pain—Triamcinolone—atopic dermatitis	0.000106	0.000397	CcSEcCtD
Nefazodone—Loss of consciousness—Prednisone—atopic dermatitis	0.000106	0.000396	CcSEcCtD
Nefazodone—Hypotension—Betamethasone—atopic dermatitis	0.000106	0.000394	CcSEcCtD
Nefazodone—Hypotension—Dexamethasone—atopic dermatitis	0.000106	0.000394	CcSEcCtD
Nefazodone—Urticaria—Hydrocortisone—atopic dermatitis	0.000105	0.000392	CcSEcCtD
Nefazodone—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000104	0.00039	CcSEcCtD
Nefazodone—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000104	0.00039	CcSEcCtD
Nefazodone—Convulsion—Prednisone—atopic dermatitis	0.000104	0.00039	CcSEcCtD
Nefazodone—Hypertension—Prednisone—atopic dermatitis	0.000104	0.000389	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000103	0.000384	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000103	0.000384	CcSEcCtD
Nefazodone—Arthralgia—Prednisone—atopic dermatitis	0.000103	0.000383	CcSEcCtD
Nefazodone—Myalgia—Prednisone—atopic dermatitis	0.000103	0.000383	CcSEcCtD
Nefazodone—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000103	0.000383	CcSEcCtD
Nefazodone—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000102	0.000382	CcSEcCtD
Nefazodone—Anxiety—Prednisone—atopic dermatitis	0.000102	0.000382	CcSEcCtD
Nefazodone—Insomnia—Betamethasone—atopic dermatitis	0.000102	0.000381	CcSEcCtD
Nefazodone—Insomnia—Dexamethasone—atopic dermatitis	0.000102	0.000381	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000102	0.000379	CcSEcCtD
Nefazodone—Paraesthesia—Dexamethasone—atopic dermatitis	0.000101	0.000379	CcSEcCtD
Nefazodone—Paraesthesia—Betamethasone—atopic dermatitis	0.000101	0.000379	CcSEcCtD
Nefazodone—Discomfort—Prednisone—atopic dermatitis	0.000101	0.000379	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisolone—atopic dermatitis	9.97e-05	0.000372	CcSEcCtD
Nefazodone—Dyspepsia—Dexamethasone—atopic dermatitis	9.94e-05	0.000371	CcSEcCtD
Nefazodone—Dyspepsia—Betamethasone—atopic dermatitis	9.94e-05	0.000371	CcSEcCtD
Nefazodone—Urticaria—Triamcinolone—atopic dermatitis	9.89e-05	0.000369	CcSEcCtD
Nefazodone—Urticaria—Methylprednisolone—atopic dermatitis	9.86e-05	0.000368	CcSEcCtD
Nefazodone—Body temperature increased—Triamcinolone—atopic dermatitis	9.84e-05	0.000367	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisone—atopic dermatitis	9.83e-05	0.000367	CcSEcCtD
Nefazodone—Oedema—Prednisone—atopic dermatitis	9.83e-05	0.000367	CcSEcCtD
Nefazodone—Abdominal pain—Methylprednisolone—atopic dermatitis	9.82e-05	0.000367	CcSEcCtD
Nefazodone—Decreased appetite—Dexamethasone—atopic dermatitis	9.82e-05	0.000367	CcSEcCtD
Nefazodone—Decreased appetite—Betamethasone—atopic dermatitis	9.82e-05	0.000367	CcSEcCtD
Nefazodone—Infection—Prednisone—atopic dermatitis	9.77e-05	0.000365	CcSEcCtD
Nefazodone—Hypersensitivity—Hydrocortisone—atopic dermatitis	9.74e-05	0.000364	CcSEcCtD
Nefazodone—Shock—Prednisone—atopic dermatitis	9.68e-05	0.000361	CcSEcCtD
Nefazodone—Pain—Betamethasone—atopic dermatitis	9.66e-05	0.000361	CcSEcCtD
Nefazodone—Pain—Dexamethasone—atopic dermatitis	9.66e-05	0.000361	CcSEcCtD
Nefazodone—Tachycardia—Prednisone—atopic dermatitis	9.6e-05	0.000358	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisone—atopic dermatitis	9.51e-05	0.000355	CcSEcCtD
Nefazodone—Asthenia—Hydrocortisone—atopic dermatitis	9.48e-05	0.000354	CcSEcCtD
Nefazodone—Anorexia—Prednisone—atopic dermatitis	9.37e-05	0.00035	CcSEcCtD
Nefazodone—Pruritus—Hydrocortisone—atopic dermatitis	9.35e-05	0.000349	CcSEcCtD
Nefazodone—Feeling abnormal—Dexamethasone—atopic dermatitis	9.31e-05	0.000348	CcSEcCtD
Nefazodone—Feeling abnormal—Betamethasone—atopic dermatitis	9.31e-05	0.000348	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	9.23e-05	0.000345	CcSEcCtD
Nefazodone—Gastrointestinal pain—Betamethasone—atopic dermatitis	9.23e-05	0.000345	CcSEcCtD
Nefazodone—Hypersensitivity—Triamcinolone—atopic dermatitis	9.17e-05	0.000342	CcSEcCtD
Nefazodone—Hypersensitivity—Methylprednisolone—atopic dermatitis	9.15e-05	0.000342	CcSEcCtD
Nefazodone—Diarrhoea—Hydrocortisone—atopic dermatitis	9.04e-05	0.000338	CcSEcCtD
Nefazodone—Urticaria—Dexamethasone—atopic dermatitis	8.97e-05	0.000335	CcSEcCtD
Nefazodone—Urticaria—Betamethasone—atopic dermatitis	8.97e-05	0.000335	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	8.96e-05	0.000335	CcSEcCtD
Nefazodone—Dizziness—Prednisolone—atopic dermatitis	8.95e-05	0.000334	CcSEcCtD
Nefazodone—Asthenia—Triamcinolone—atopic dermatitis	8.93e-05	0.000333	CcSEcCtD
Nefazodone—Body temperature increased—Dexamethasone—atopic dermatitis	8.93e-05	0.000333	CcSEcCtD
Nefazodone—Body temperature increased—Betamethasone—atopic dermatitis	8.93e-05	0.000333	CcSEcCtD
Nefazodone—Abdominal pain—Dexamethasone—atopic dermatitis	8.93e-05	0.000333	CcSEcCtD
Nefazodone—Abdominal pain—Betamethasone—atopic dermatitis	8.93e-05	0.000333	CcSEcCtD
Nefazodone—Asthenia—Methylprednisolone—atopic dermatitis	8.91e-05	0.000333	CcSEcCtD
Nefazodone—Insomnia—Prednisone—atopic dermatitis	8.89e-05	0.000332	CcSEcCtD
Nefazodone—Paraesthesia—Prednisone—atopic dermatitis	8.83e-05	0.00033	CcSEcCtD
Nefazodone—Pruritus—Triamcinolone—atopic dermatitis	8.8e-05	0.000329	CcSEcCtD
Nefazodone—Pruritus—Methylprednisolone—atopic dermatitis	8.79e-05	0.000328	CcSEcCtD
Nefazodone—Dizziness—Hydrocortisone—atopic dermatitis	8.74e-05	0.000326	CcSEcCtD
Nefazodone—Dyspepsia—Prednisone—atopic dermatitis	8.66e-05	0.000323	CcSEcCtD
Nefazodone—Decreased appetite—Prednisone—atopic dermatitis	8.55e-05	0.000319	CcSEcCtD
Nefazodone—Rash—Prednisolone—atopic dermatitis	8.53e-05	0.000319	CcSEcCtD
Nefazodone—Dermatitis—Prednisolone—atopic dermatitis	8.52e-05	0.000318	CcSEcCtD
Nefazodone—Diarrhoea—Methylprednisolone—atopic dermatitis	8.5e-05	0.000317	CcSEcCtD
Nefazodone—Headache—Prednisolone—atopic dermatitis	8.48e-05	0.000317	CcSEcCtD
Nefazodone—Constipation—Prednisone—atopic dermatitis	8.41e-05	0.000314	CcSEcCtD
Nefazodone—Vomiting—Hydrocortisone—atopic dermatitis	8.4e-05	0.000314	CcSEcCtD
Nefazodone—Rash—Hydrocortisone—atopic dermatitis	8.33e-05	0.000311	CcSEcCtD
Nefazodone—Dermatitis—Hydrocortisone—atopic dermatitis	8.33e-05	0.000311	CcSEcCtD
Nefazodone—Headache—Hydrocortisone—atopic dermatitis	8.28e-05	0.000309	CcSEcCtD
Nefazodone—Dizziness—Triamcinolone—atopic dermatitis	8.23e-05	0.000307	CcSEcCtD
Nefazodone—Dizziness—Methylprednisolone—atopic dermatitis	8.21e-05	0.000307	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisone—atopic dermatitis	8.1e-05	0.000303	CcSEcCtD
Nefazodone—Asthenia—Betamethasone—atopic dermatitis	8.1e-05	0.000303	CcSEcCtD
Nefazodone—Asthenia—Dexamethasone—atopic dermatitis	8.1e-05	0.000303	CcSEcCtD
Nefazodone—Gastrointestinal pain—Prednisone—atopic dermatitis	8.04e-05	0.0003	CcSEcCtD
Nefazodone—Nausea—Prednisolone—atopic dermatitis	8.04e-05	0.0003	CcSEcCtD
Nefazodone—Pruritus—Dexamethasone—atopic dermatitis	7.99e-05	0.000298	CcSEcCtD
Nefazodone—Pruritus—Betamethasone—atopic dermatitis	7.99e-05	0.000298	CcSEcCtD
Nefazodone—Vomiting—Triamcinolone—atopic dermatitis	7.91e-05	0.000296	CcSEcCtD
Nefazodone—Vomiting—Methylprednisolone—atopic dermatitis	7.9e-05	0.000295	CcSEcCtD
Nefazodone—Nausea—Hydrocortisone—atopic dermatitis	7.85e-05	0.000293	CcSEcCtD
Nefazodone—Rash—Triamcinolone—atopic dermatitis	7.85e-05	0.000293	CcSEcCtD
Nefazodone—Dermatitis—Triamcinolone—atopic dermatitis	7.84e-05	0.000293	CcSEcCtD
Nefazodone—Rash—Methylprednisolone—atopic dermatitis	7.83e-05	0.000292	CcSEcCtD
Nefazodone—Dermatitis—Methylprednisolone—atopic dermatitis	7.82e-05	0.000292	CcSEcCtD
Nefazodone—Urticaria—Prednisone—atopic dermatitis	7.81e-05	0.000292	CcSEcCtD
Nefazodone—Headache—Triamcinolone—atopic dermatitis	7.8e-05	0.000291	CcSEcCtD
Nefazodone—Headache—Methylprednisolone—atopic dermatitis	7.78e-05	0.000291	CcSEcCtD
Nefazodone—Abdominal pain—Prednisone—atopic dermatitis	7.77e-05	0.00029	CcSEcCtD
Nefazodone—Body temperature increased—Prednisone—atopic dermatitis	7.77e-05	0.00029	CcSEcCtD
Nefazodone—Diarrhoea—Betamethasone—atopic dermatitis	7.73e-05	0.000289	CcSEcCtD
Nefazodone—Diarrhoea—Dexamethasone—atopic dermatitis	7.73e-05	0.000289	CcSEcCtD
Nefazodone—Dizziness—Betamethasone—atopic dermatitis	7.47e-05	0.000279	CcSEcCtD
Nefazodone—Dizziness—Dexamethasone—atopic dermatitis	7.47e-05	0.000279	CcSEcCtD
Nefazodone—Nausea—Triamcinolone—atopic dermatitis	7.39e-05	0.000276	CcSEcCtD
Nefazodone—Nausea—Methylprednisolone—atopic dermatitis	7.38e-05	0.000275	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisone—atopic dermatitis	7.25e-05	0.000271	CcSEcCtD
Nefazodone—Vomiting—Dexamethasone—atopic dermatitis	7.18e-05	0.000268	CcSEcCtD
Nefazodone—Vomiting—Betamethasone—atopic dermatitis	7.18e-05	0.000268	CcSEcCtD
Nefazodone—Rash—Dexamethasone—atopic dermatitis	7.12e-05	0.000266	CcSEcCtD
Nefazodone—Rash—Betamethasone—atopic dermatitis	7.12e-05	0.000266	CcSEcCtD
Nefazodone—Dermatitis—Dexamethasone—atopic dermatitis	7.11e-05	0.000266	CcSEcCtD
Nefazodone—Dermatitis—Betamethasone—atopic dermatitis	7.11e-05	0.000266	CcSEcCtD
Nefazodone—Headache—Dexamethasone—atopic dermatitis	7.07e-05	0.000264	CcSEcCtD
Nefazodone—Headache—Betamethasone—atopic dermatitis	7.07e-05	0.000264	CcSEcCtD
Nefazodone—Asthenia—Prednisone—atopic dermatitis	7.06e-05	0.000264	CcSEcCtD
Nefazodone—Pruritus—Prednisone—atopic dermatitis	6.96e-05	0.00026	CcSEcCtD
Nefazodone—Diarrhoea—Prednisone—atopic dermatitis	6.73e-05	0.000251	CcSEcCtD
Nefazodone—Nausea—Dexamethasone—atopic dermatitis	6.71e-05	0.000251	CcSEcCtD
Nefazodone—Nausea—Betamethasone—atopic dermatitis	6.71e-05	0.000251	CcSEcCtD
Nefazodone—Dizziness—Prednisone—atopic dermatitis	6.5e-05	0.000243	CcSEcCtD
Nefazodone—Vomiting—Prednisone—atopic dermatitis	6.25e-05	0.000234	CcSEcCtD
Nefazodone—Rash—Prednisone—atopic dermatitis	6.2e-05	0.000232	CcSEcCtD
Nefazodone—Dermatitis—Prednisone—atopic dermatitis	6.19e-05	0.000231	CcSEcCtD
Nefazodone—Headache—Prednisone—atopic dermatitis	6.16e-05	0.00023	CcSEcCtD
Nefazodone—Nausea—Prednisone—atopic dermatitis	5.84e-05	0.000218	CcSEcCtD
Nefazodone—ADRA1B—Signaling by GPCR—TAC1—atopic dermatitis	1.45e-05	0.000971	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—NPS—atopic dermatitis	1.45e-05	0.000971	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—NPS—atopic dermatitis	1.45e-05	0.00097	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—TAC1—atopic dermatitis	1.45e-05	0.00097	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL27—atopic dermatitis	1.45e-05	0.00097	CbGpPWpGaD
Nefazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.45e-05	0.00097	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCR3—atopic dermatitis	1.44e-05	0.000968	CbGpPWpGaD
Nefazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.44e-05	0.000965	CbGpPWpGaD
Nefazodone—ADRA2A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	1.44e-05	0.000962	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—CCR5—atopic dermatitis	1.43e-05	0.00096	CbGpPWpGaD
Nefazodone—ADRA2A—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.43e-05	0.000959	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CXCR3—atopic dermatitis	1.42e-05	0.000952	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CXCR3—atopic dermatitis	1.42e-05	0.000951	CbGpPWpGaD
Nefazodone—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.42e-05	0.000951	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—TAC1—atopic dermatitis	1.42e-05	0.00095	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—NPS—atopic dermatitis	1.42e-05	0.00095	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	1.42e-05	0.000948	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL5—atopic dermatitis	1.41e-05	0.000943	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GLB1—atopic dermatitis	1.41e-05	0.000942	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CXCR3—atopic dermatitis	1.39e-05	0.000931	CbGpPWpGaD
Nefazodone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.38e-05	0.000923	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	1.37e-05	0.000917	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—KIF3A—atopic dermatitis	1.36e-05	0.000912	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ADSL—atopic dermatitis	1.35e-05	0.000903	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL5—atopic dermatitis	1.35e-05	0.000903	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL5—atopic dermatitis	1.35e-05	0.000902	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL27—atopic dermatitis	1.35e-05	0.000901	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCR3—atopic dermatitis	1.34e-05	0.000899	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.33e-05	0.00089	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL17—atopic dermatitis	1.33e-05	0.000888	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CXCL10—atopic dermatitis	1.32e-05	0.000885	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL5—atopic dermatitis	1.32e-05	0.000883	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	1.32e-05	0.000882	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	1.32e-05	0.000882	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—NPS—atopic dermatitis	1.31e-05	0.000881	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—TAC1—atopic dermatitis	1.31e-05	0.000881	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—KIF3A—atopic dermatitis	1.3e-05	0.000873	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL17—atopic dermatitis	1.3e-05	0.00087	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	1.29e-05	0.000865	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CXCR3—atopic dermatitis	1.29e-05	0.000864	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—NPS—atopic dermatitis	1.29e-05	0.000862	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—TAC1—atopic dermatitis	1.29e-05	0.000862	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CXCL10—atopic dermatitis	1.27e-05	0.000848	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	1.26e-05	0.000846	CbGpPWpGaD
Nefazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.25e-05	0.000838	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	1.24e-05	0.000829	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	1.24e-05	0.000829	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL11—atopic dermatitis	1.23e-05	0.000825	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CMA1—atopic dermatitis	1.23e-05	0.000825	CbGpPWpGaD
Nefazodone—HTR2A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.23e-05	0.000821	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	1.22e-05	0.00082	CbGpPWpGaD
Nefazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.22e-05	0.00082	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL5—atopic dermatitis	1.22e-05	0.000819	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	1.21e-05	0.000808	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	1.21e-05	0.000808	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CXCL10—atopic dermatitis	1.2e-05	0.000804	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	1.2e-05	0.000802	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	1.2e-05	0.000801	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	1.2e-05	0.000801	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—KIF3A—atopic dermatitis	1.18e-05	0.000792	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL11—atopic dermatitis	1.18e-05	0.000789	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CMA1—atopic dermatitis	1.18e-05	0.000789	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	1.17e-05	0.000786	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	1.16e-05	0.000779	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	1.16e-05	0.000775	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—STAT6—atopic dermatitis	1.16e-05	0.000775	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CXCL10—atopic dermatitis	1.15e-05	0.00077	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.15e-05	0.000769	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	1.14e-05	0.000766	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CCL5—atopic dermatitis	1.14e-05	0.000762	CbGpPWpGaD
Nefazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.14e-05	0.000762	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.12e-05	0.000753	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	1.11e-05	0.000745	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—STAT6—atopic dermatitis	1.11e-05	0.000742	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	1.1e-05	0.000738	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—CXCL8—atopic dermatitis	1.1e-05	0.000735	CbGpPWpGaD
Nefazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.09e-05	0.000732	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CCL5—atopic dermatitis	1.09e-05	0.00073	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	1.08e-05	0.00072	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL11—atopic dermatitis	1.07e-05	0.000716	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CMA1—atopic dermatitis	1.07e-05	0.000716	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GLB1—atopic dermatitis	1.06e-05	0.000711	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—CXCL8—atopic dermatitis	1.05e-05	0.000703	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	1.05e-05	0.000701	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	1.05e-05	0.000701	CbGpPWpGaD
Nefazodone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.05e-05	0.000701	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.04e-05	0.0007	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CXCL10—atopic dermatitis	1.04e-05	0.000698	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	1.04e-05	0.000696	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CCL5—atopic dermatitis	1.03e-05	0.000692	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	1.03e-05	0.00069	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.03e-05	0.000688	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CCR5—atopic dermatitis	1.03e-05	0.000687	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	1.02e-05	0.000684	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ADSL—atopic dermatitis	1.02e-05	0.000682	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	1.01e-05	0.000676	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—STAT6—atopic dermatitis	1.01e-05	0.000673	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR3—atopic dermatitis	1e-05	0.000672	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GLB1—atopic dermatitis	1e-05	0.00067	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CCL5—atopic dermatitis	9.89e-06	0.000663	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CCL5—atopic dermatitis	9.88e-06	0.000662	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	9.84e-06	0.000659	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CCR5—atopic dermatitis	9.81e-06	0.000657	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	9.73e-06	0.000652	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	9.73e-06	0.000652	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	9.67e-06	0.000648	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR3—atopic dermatitis	9.61e-06	0.000644	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ADSL—atopic dermatitis	9.59e-06	0.000642	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	9.52e-06	0.000638	CbGpPWpGaD
Nefazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	9.49e-06	0.000635	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	9.48e-06	0.000635	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	9.36e-06	0.000627	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	9.32e-06	0.000625	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CCR5—atopic dermatitis	9.31e-06	0.000624	CbGpPWpGaD
Nefazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	9.29e-06	0.000622	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	9.14e-06	0.000613	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NPS—atopic dermatitis	8.99e-06	0.000602	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	8.99e-06	0.000602	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	8.99e-06	0.000602	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	8.97e-06	0.000601	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NPS—atopic dermatitis	8.95e-06	0.000599	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TAC1—atopic dermatitis	8.95e-06	0.000599	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CCR5—atopic dermatitis	8.91e-06	0.000597	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	8.9e-06	0.000596	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	8.82e-06	0.000591	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	8.79e-06	0.000589	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	8.77e-06	0.000588	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	8.72e-06	0.000584	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	8.72e-06	0.000584	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	8.66e-06	0.00058	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NPS—atopic dermatitis	8.56e-06	0.000574	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TAC1—atopic dermatitis	8.56e-06	0.000574	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	8.53e-06	0.000572	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	8.4e-06	0.000563	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL5—atopic dermatitis	8.36e-06	0.00056	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL5—atopic dermatitis	8.32e-06	0.000557	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	8.16e-06	0.000547	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	8.13e-06	0.000545	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	8.1e-06	0.000542	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	8.08e-06	0.000541	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	7.96e-06	0.000533	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	7.93e-06	0.000531	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	7.92e-06	0.00053	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	7.77e-06	0.00052	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NPS—atopic dermatitis	7.77e-06	0.00052	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	7.62e-06	0.00051	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	7.61e-06	0.000509	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	7.61e-06	0.000509	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	7.46e-06	0.0005	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IL2—atopic dermatitis	7.4e-06	0.000496	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	7.35e-06	0.000493	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	7.35e-06	0.000493	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL5—atopic dermatitis	7.22e-06	0.000484	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	7.13e-06	0.000477	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	7.09e-06	0.000475	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	7.07e-06	0.000474	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	7.07e-06	0.000473	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	7.07e-06	0.000473	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	6.93e-06	0.000464	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	6.79e-06	0.000455	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	6.57e-06	0.00044	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GLB1—atopic dermatitis	6.54e-06	0.000438	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PPARA—atopic dermatitis	6.31e-06	0.000423	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADSL—atopic dermatitis	6.27e-06	0.00042	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.23e-06	0.000417	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	6.2e-06	0.000415	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	6.16e-06	0.000412	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	6.14e-06	0.000411	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	6.1e-06	0.000409	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	6.03e-06	0.000404	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	5.95e-06	0.000399	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	5.93e-06	0.000397	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	5.92e-06	0.000397	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	5.84e-06	0.000391	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NGF—atopic dermatitis	5.68e-06	0.000381	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	5.67e-06	0.00038	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	5.66e-06	0.000379	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NGF—atopic dermatitis	5.65e-06	0.000379	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	5.63e-06	0.000377	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	5.6e-06	0.000375	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	5.53e-06	0.00037	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	5.5e-06	0.000368	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	5.41e-06	0.000362	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	5.41e-06	0.000362	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	5.39e-06	0.000361	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.38e-06	0.00036	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	5.38e-06	0.00036	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	5.3e-06	0.000355	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.27e-06	0.000353	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	5.26e-06	0.000353	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	5.19e-06	0.000348	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	5.15e-06	0.000345	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	5.14e-06	0.000345	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	5.04e-06	0.000337	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PPARA—atopic dermatitis	4.98e-06	0.000334	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NGF—atopic dermatitis	4.91e-06	0.000329	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.9e-06	0.000328	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	4.89e-06	0.000327	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	4.82e-06	0.000323	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	4.81e-06	0.000322	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	4.79e-06	0.000321	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	4.78e-06	0.00032	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	4.69e-06	0.000314	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	4.68e-06	0.000313	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	4.68e-06	0.000313	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	4.67e-06	0.000313	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	4.66e-06	0.000312	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	4.57e-06	0.000306	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPARA—atopic dermatitis	4.56e-06	0.000306	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	4.47e-06	0.000299	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	4.46e-06	0.000299	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	4.45e-06	0.000298	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	4.34e-06	0.000291	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	4.25e-06	0.000285	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	4.05e-06	0.000271	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.96e-06	0.000266	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.68e-06	0.000247	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARA—atopic dermatitis	3.44e-06	0.000231	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	3.34e-06	0.000224	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	3.32e-06	0.000223	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARA—atopic dermatitis	3.25e-06	0.000217	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—atopic dermatitis	3.19e-06	0.000214	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	3.18e-06	0.000213	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	3.18e-06	0.000213	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—atopic dermatitis	3.18e-06	0.000213	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	3.16e-06	0.000212	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	3.04e-06	0.000204	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	3.03e-06	0.000203	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	2.94e-06	0.000197	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	2.92e-06	0.000196	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	2.89e-06	0.000193	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	2.83e-06	0.000189	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	2.8e-06	0.000188	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—atopic dermatitis	2.76e-06	0.000185	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	2.75e-06	0.000184	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	2.7e-06	0.000181	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	2.69e-06	0.00018	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	2.63e-06	0.000176	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2.54e-06	0.00017	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	2.51e-06	0.000168	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	2.5e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	2.49e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	2.31e-06	0.000155	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.12e-06	0.000142	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.88e-06	0.000126	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.87e-06	0.000125	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	1.79e-06	0.00012	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.62e-06	0.000109	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.59e-06	0.000106	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.48e-06	9.88e-05	CbGpPWpGaD
